Inhibitors of 2-Ketoglutarate-dependent Dioxygenases Block Aspartyl β-Hydroxylation of Recombinant Human Factor IX in Several Mammalian Expression Systems

作者: C K Derian , W VanDusen , C T Przysiecki , P N Walsh , K L Berkner

DOI: 10.1016/S0021-9258(18)83472-X

关键词: StereochemistryEnzymeRecombinant DNAGlycoproteinSite-directed mutagenesisAmino acidGla domainFactor IXHydroxylationChemistryBiochemistry

摘要: Abstract While a role has been ascribed to the gamma-carboxyglutamate (Gla) residues in vitamin K-dependent coagulation proteins and enzyme catalyzing this posttranslational modification identified partially characterized, both functional significance of second posttranslationally synthesized amino acid found these proteins, beta-hydroxyaspartate (Hya), aspartyl beta-hydroxylating remain be determined. We now report that inhibitors 2-ketoglutarate-dependent dioxygenases, such as dipyridyl, o-phenanthroline, pyridine 2,4-dicarboxylate, block hydroxylation Asp64 recombinant factor IX molecules produced three different mammalian expression systems. This was not inhibited by specific copper chelators 2,9-dimethylphenanthroline or D-penicillamine. The Gla levels were unaffected compounds demonstrate carboxylation proceeds independently hydroxylation. Using Hya-deficient we residue does play significant binding endothelial cells under equilibrium conditions. From additional studies have concluded domain is major cell IX. Furthermore, contrast demonstrating marked loss one-stage clotting activity factors following site-directed mutations neutral basic (Rees, D. J. G., Jones, I. M., Handford, P. A., Walter, S. J., Esnouf, M. P., Smith, K. Brownlee, G. (1988) EMBO 7, 2053-2061), decrease with manner may prove more appropriate elucidate function Hya than those mutagenesis.

参考文章(28)
Mendel Friedman, Chemical Basis for Pharmacological and Therapeutic Actions of Penicillamine Protein Crosslinking. ,vol. 70, pp. 649- 673 ,(1977) , 10.1007/978-1-4757-9113-6_36
D. J. Rees, I. M. Jones, P. A. Handford, S. J. Walter, M. P. Esnouf, K. J. Smith, G. G. Brownlee, The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX. The EMBO Journal. ,vol. 7, pp. 2053- 2061 ,(1988) , 10.1002/J.1460-2075.1988.TB03045.X
Daniel A. Walz, Current Advances in Vitamin K Research Journal of Nutrition. ,vol. 120, pp. 321- 322 ,(1990) , 10.1093/JN/120.3.321
CT Esmon, JW Suttie, CM Jackson, The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin. Journal of Biological Chemistry. ,vol. 250, pp. 4095- 4099 ,(1975) , 10.1016/S0021-9258(19)41391-4
A K Ohlin, G Landes, P Bourdon, C Oppenheimer, R Wydro, J Stenflo, Beta-hydroxyaspartic acid in the first epidermal growth factor-like domain of protein C. Its role in Ca2+ binding and biological activity. Journal of Biological Chemistry. ,vol. 263, pp. 19240- 19248 ,(1988) , 10.1016/S0021-9258(18)37415-5
R J Kaufman, L C Wasley, B C Furie, B Furie, C B Shoemaker, Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells. Journal of Biological Chemistry. ,vol. 261, pp. 9622- 9628 ,(1986) , 10.1016/S0021-9258(18)67559-3
P Fernlund, J Stenflo, Beta-hydroxyaspartic acid in vitamin K-dependent proteins. Journal of Biological Chemistry. ,vol. 258, pp. 12509- 12512 ,(1983) , 10.1016/S0021-9258(17)44205-0
C. Richard Savage, John H. Hash, Stanley Cohen, Epidermal growth factor. Location of disulfide bonds. Journal of Biological Chemistry. ,vol. 248, pp. 7669- 7672 ,(1973) , 10.1016/S0021-9258(19)43242-0
S S Ahmad, R Rawala-Sheikh, P N Walsh, Comparative interactions of factor IX and factor IXa with human platelets Journal of Biological Chemistry. ,vol. 264, pp. 3244- 3251 ,(1989) , 10.1016/S0021-9258(18)94058-5